BioSpace News Archive

Business

Delcath Enhances Board of Directors With Appointment of Industry Veteran, Dr. Simon Pedder

Dr. Pedder currently serves as Chief Business and Strategy Officer at Athenex, Inc.

November 20, 2017

·

5 min read

Umecrine Cognition Announces First Patient Included in Clinical Phase IIa Study in Patients With Sleep Disorder

The objectives of the study are to assess the safety and pharmacokinetics, and to evaluate the exploratory efficacy of GR3027 in patients with idiopathic hypersomnia.

November 20, 2017

·

2 min read

Business

India Globalization Capital Reports Second Quarter 2018 Financial Results and Operational Highlights

Cost of revenue for the three months ended September 30, 2017 was $163,170 as compared to $90,534 for the three months ended September 30, 2016.

November 20, 2017

·

8 min read

Business

Johnson & Johnson Medical Devices Companies Unveils State of the Art “Engineering Studio” at Texas Medical Center to Accelerate Medical Devices Development

Housed within the TMC Innovation Institute, the 26,000-square-foot facility will host JJMDC R&D staff working on select internal projects along with strategically aligned external ventures of JJMDC.

November 20, 2017

·

4 min read

Biotech Beach

Mirati Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Mirati Therapeutics today announced the closing of its previously announced underwritten public offering of 2,938,986 shares of its common stock at a public offering price of $13.00 per share.

November 20, 2017

·

3 min read

Deals

Arsanis Announces Closing of Initial Public Offering

The gross proceeds to Arsanis from the offering were $46.0 million, before deducting underwriting discounts and commissions and other offering expenses.

November 20, 2017

·

3 min read

Business

Enanta Pharmaceuticals Reports Financial Results for its Fourth Quarter and Year Ended September 30, 2017

Cash and marketable securities totaled $293.7 million at September 30, 2017.

November 20, 2017

·

12 min read

Drug Development

Revance Announces Orphan Drug Designation of RT002 for the Treatment of Cervical Dystonia

The FDA Office of Orphan Products Development grants orphan designation to drugs and biologics intended for treatment of rare diseases or conditions that affect fewer than 200,000 people in the U.S.

November 20, 2017

·

6 min read

Lone Star Bio

New Study Proves 2-Minute Cycle With Pulsed Xenon UV Significantly Reduces OR Contamination

The Xenex robot eliminated 72% more Pathogens than manual cleaning alone.

November 20, 2017

·

3 min read

FDA

U.S. FDA Approves Kaleo’s AUVI-Q (Epinephrine Injection, USP) 0.1 mg Auto-Injector for Life-Threatening Allergic Reactions in Infants and Small Children

AUVI-Q is a compact epinephrine auto-injector with industry-first features, including a voice prompt system that guides a user with step-by-step instructions through the delivery process, and a needle that automatically retracts following administration.

November 20, 2017

·

9 min read